HomeCompareKMSTF vs PLD

KMSTF vs PLD: Dividend Comparison 2026

KMSTF yields 62.31% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.18M in total portfolio value· pulled ahead in Year 9
10 years
KMSTF
KMSTF
● Live price
62.31%
Share price
$3.21
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$729.0K
Annual income
$175,361.30
Full KMSTF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — KMSTF vs PLD

📍 PLD pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKMSTFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KMSTF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KMSTF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KMSTF
Annual income on $10K today (after 15% tax)
$5,295.95/yr
After 10yr DRIP, annual income (after tax)
$149,057.10/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $3,889,059.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KMSTF + PLD for your $10,000?

KMSTF: 50%PLD: 50%
100% PLD50/50100% KMSTF
Portfolio after 10yr
$3.32M
Annual income
$2,463,043.24/yr
Blended yield
74.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

KMSTF
No analyst data
Altman Z
-328.3
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KMSTF buys
0
PLD buys
0
No recent congressional trades found for KMSTF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKMSTFPLD
Forward yield62.31%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$729.0K$5.91M
Annual income after 10y$175,361.30$4,750,725.19
Total dividends collected$608.8K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: KMSTF vs PLD ($10,000, DRIP)

YearKMSTF PortfolioKMSTF Income/yrPLD PortfolioPLD Income/yrGap
1$16,931$6,230.53$11,241$540.96+$5.7KKMSTF
2$27,974$9,858.52$13,019$991.13+$15.0KKMSTF
3$45,156$15,223.51$15,801$1,870.97+$29.4KKMSTF
4$71,283$22,966.14$20,609$3,701.21+$50.7KKMSTF
5$110,155$33,882.50$29,919$7,867.97+$80.2KKMSTF
6$166,800$48,934.07$50,631$18,617.74+$116.2KKMSTF
7$247,726$69,249.85$105,528$51,352.20+$142.2KKMSTF
8$361,186$96,119.21$287,364$174,449.42+$73.8KKMSTF
9← crossover$517,443$130,974.20$1,081,760$774,280.77$564.3KPLD
10$729,026$175,361.30$5,908,209$4,750,725.19$5.18MPLD

KMSTF vs PLD: Complete Analysis 2026

KMSTFStock

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was founded in 2008 and is based in Ness Ziona, Israel.

Full KMSTF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this KMSTF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KMSTF vs SCHDKMSTF vs JEPIKMSTF vs OKMSTF vs KOKMSTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.